Composition for treating diabetes and metabolic disorders with quercetin, myrcetin and chlorogenic acid
A technology of myricetin and composition, which is applied in the fields of compositions for treating diabetes and metabolic diseases, compositions for glycemic index, and compositions for treating or preventing diabetes and/or obesity. practical issues
Active Publication Date: 2013-06-26
ATM麦特保利公司
View PDF0 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
To reap the many flavonoid health benefits, large doses are required, which are often impractical and prohibitively expensive
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0049] Gelatin capsules containing 50 mg of chlorogenic acid, 200 mg of myricetin and 200 mg of quercetin were administered orally to the subject three times a day with food.
Embodiment 2
[0051] Tablets containing sodium citrate, 100 mg carboxymethylcellulose, 100 mg chlorogenic acid, 300 mg myricetin, and 300 mg quercetin were orally administered once a day after waking up.
Embodiment 3
[0053] The bread was manufactured to include 50mg of chlorogenic acid, 150mg of myricetin and 50mg of quercetin per 15g of total carbohydrates in the bread.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
A composition and method for treating diabetes and metabolic disorders, and for achieving weight loss in a subject comprising a combination of naturally occurring compounds is provided.
Description
[0001] This application claims the benefit of US Provisional Application No. 60 / 895,486, filed March 19, 2007, which is hereby incorporated in its entirety. Background technique [0002] According to the American Heart Association, more than 60 percent of men and almost 50 percent of women are overweight. In addition, nearly 13% and 18% of men and women were relatively obese. Being sedentary and being overweight can lead to metabolic syndrome, which is a group of metabolic risk factors in a person. These include: (a) central obesity, manifested by excess abdominal and periabdominal adipose tissue; (b) atherogenic dyslipidemia (dyslipidemia, primarily high triglycerides and low HDL cholesterol, which produces plaque buildup in the artery walls); (c) elevated blood pressure (130 / 85 mmHg or higher); (d) insulin resistance or glucose intolerance (the body's inability to use insulin or blood sugar properly); (e ) a prothrombotic state (eg, high fibrinogen in the blood or a plasmi...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/216A61K31/353A61P3/00A61P3/10A23L1/30
CPCA23V2002/00A61K31/216A61K31/192A61K31/353A61K31/352A23L1/3002A23L33/105A61P3/00A61P3/10A61P3/04A61P43/00A61K2300/00A23V2200/30A23V2250/21168A23V2250/21A23V2200/328
Inventor M·J·阿伦斯D·L·汤普森
Owner ATM麦特保利公司